US Edition
Published • loading... • Updated
Tyra Biosciences Adds Former Acceleron CEO Habib Dable to Board
Summary by Citybiz
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Tyra Biosciences Adds Former Acceleron CEO Habib Dable to Board
Tyra Biosciences has appointed longtime biopharma executive Habib Dable to its board of directors as the clinical-stage company advances lead drug candidate dabogratinib and prepares for a potential next phase of growth. The board addition brings more than three decades of pharmaceutical leadership experience to Tyra as it develops precision medicines targeting fibroblast growth factor receptor, or FGFR, biology. The company is focused on oncolo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
